What AI says about CANbridge Pharmaceuticals

Canbridge is a global biopharmaceutical company founded in 2012 that develops and delivers therapies for rare diseases and rare oncology, leveraging its China foundation. The company's pipeline includes gene therapies, and its products include Hunterase ERT and Livmarli IBAT inhibitor.